​

Checkpoint Therapeutics Ownership | Who Owns Checkpoint Therapeutics?

OverviewForecastFinancialsChart

Checkpoint Therapeutics Ownership Summary

Checkpoint Therapeutics is owned by 53.47% institutional investors, 14.05% insiders, and 32.48% retail investors. 683 capital management is the largest institutional shareholder, holding 0% of CKPT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.48% of its assets in Checkpoint Therapeutics shares.

CKPT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCheckpoint Therapeutics53.47%14.05%32.48%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
683 capital management---
Geode capital management---
Yakira capital management---
Magnus financial group---
Jbf capital---
Prelude capital management---
Marshall wace, llp---
Cordant---
Barclays---
Gabelli funds---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
683 capital management---
Geode capital management---
Yakira capital management---
Magnus financial group---
Jbf capital---
Prelude capital management---
Marshall wace, llp---
Cordant---
Barclays---
Gabelli funds---

Top Buyers

HolderShares% AssetsChange
Jpmorgan chase---1.00
Us bancorp \de\---22.00
Larson financial group---100.00
Tsfg---300.00
Wells fargo & company/mn---1.00K

Top Sellers

HolderShares% AssetsChange
Armistice capital---4.46M
Highbridge capital management---3.83M
Toronto dominion bank---3.42M
Glazer capital---3.17M
Vanguard group---2.01M

Sold Out

HolderChange
Jpmorgan chase-1.00
Us bancorp \de\-22.00
Larson financial group-100.00
Tsfg-300.00
Wells fargo & company/mn-1.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20259226.03%31,986,847189.34%538.15%6124.49%1536.36%
Dec 31, 20247352.08%11,054,93943.91%258.08%4968.97%1183.33%
Sep 30, 202448-7,681,83830.95%176.90%2931.82%6-33.33%
Jun 30, 20244811.63%5,866,2378.72%165.98%22-9-10.00%
Mar 31, 202443-6.52%5,395,70910.46%162.41%22-21.43%10-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.29M1.48%-
Vanguard US Total Market Shares ETF1.09M1.30%-
GAMCO Intl SICAV Merger Arbtrg I (USD)769.79K0.88%769.79K
Vanguard Institutional Extnd Mkt Idx Tr645.62K0.74%-
Stork Fund Dynamic MultiStrategies O EUR447.50K0.51%447.50K
Fidelity Extended Market Index217.83K0.25%-2.08K
GDL Fund205.00K0.24%205.00K
BlackRock Extended Equity Market K52.75K0.12%-22.00
Extended Equity Market Fund K93.81K0.11%288.00
Accelerate Arbitrage ETF90.00K0.10%-2.50K

Recent Insider Transactions

DateNameRoleActivityValue
May 29, 2025Fortress Biotech, Inc.-Sell$129.00K
Apr 02, 2025Oliviero James F III CEO, President and DirectorSell$60.96K
Apr 01, 2025GRAY WILLIAM GARRETT Chief Financial OfficerSell$49.90K
Feb 07, 2025Oliviero James F III CEO, President and DirectorSell$31.48K
Feb 10, 2025Oliviero James F III CEO, President and DirectorSell$32.54K

Insider Transactions Trends

DateBuySell
2025 Q2-2
2025 Q1-3
2024 Q4-3
2024 Q3--
2024 Q2-2

CKPT Ownership FAQ

Who Owns Checkpoint Therapeutics?

Checkpoint Therapeutics shareholders are primarily institutional investors at 53.47%, followed by 14.05% insiders and 32.48% retail investors. The average institutional ownership in Checkpoint Therapeutics's industry, Biotech Stocks , is 64.05%, which Checkpoint Therapeutics falls below.

Who owns the most shares of Checkpoint Therapeutics?

Checkpoint Therapeutics’s largest shareholders are 683 capital management (0 shares, 0%), Geode capital management (0 shares, 0%), and Yakira capital management (0 shares, 0%). Together, they hold 0% of Checkpoint Therapeutics’s total shares outstanding.

Does Blackrock own Checkpoint Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Checkpoint Therapeutics.

Who is Checkpoint Therapeutics’s biggest shareholder by percentage of total assets invested?

683 capital management is Checkpoint Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Checkpoint Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Checkpoint Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Checkpoint Therapeutics shares, with 1.48% of its total shares outstanding invested in 1.29M Checkpoint Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools